| Literature DB >> 23019432 |
Kay M Brummond1, John R Goodell, Matthew G Laporte, Lirong Wang, Xiang-Qun Xie.
Abstract
The synthesis of a library of tetrahydro-β-carboline-containing compounds in milligram quantities is described. Among the unique heterocyclic frameworks are twelve tetrahydroindolizinoindoles, six tetrahydrocyclobutanindoloquinolizinones and three tetrahydrocyclopentenoneindolizinoindolones. These compounds were selected from a virtual combinatorial library of 11,478 compounds. Physical chemical properties were calculated and most of them are in accordance with Lipinski's rules. Virtual docking and ligand-based target evaluations were performed for the β-carboline library compounds and selected synthetic intermediates to assess the therapeutic potential of these small organic molecules. These compounds have been deposited into the NIH Molecular Repository (MLSMR) and may target proteins such as histone deacetylase 4, endothelial nitric oxide synthase, 5-hydroxytryptamine receptor 6 and mitogen-activated protein kinase 1. These in silico screening results aim to add value to the β-carboline library of compounds for those interested in probes of these targets.Entities:
Keywords: biological activity; chemical diversity; diversity-oriented synthesis; in silico screening; β-carboline
Year: 2012 PMID: 23019432 PMCID: PMC3458722 DOI: 10.3762/bjoc.8.117
Source DB: PubMed Journal: Beilstein J Org Chem ISSN: 1860-5397 Impact factor: 2.883
Figure 1Tetrahydro-β-carboline containing scaffolds 1–3.
Library of N-tosyltetrahydro-β-carbolinepyrrolines 7{1–7}.
| entry | R1 | yield of | anti:synb | yield of | purityc | |
| 1 | 68 | NA | 28 | 98% | ||
| 2 | 74 | 2.5:1 | 17 syn- | 98% | ||
| 3 | 81 | 2.1:1 | 23 syn- | 98% | ||
| 4 | 73 | 2.4:1 | 11 anti- | 98% | ||
| 5 | 75 | 2.4:1 | 34 anti- | 98% | ||
| 6 | 74 | 1.3:1 | 35 anti- | 98% | ||
| 7 | 54 | 2.7:1 | 12 anti- | 98% | ||
| 8 | 89 | 2.3:1 | NDd | |||
| 9 | 78 | 1.2:1 | NDe | |||
| 10 | 80 | 1:1.1 | NDd | |||
| 11 | 70 | 1.3:1 | NDe | |||
| 12 | 80 | 3.5:1 | NDe | |||
| 13 | 63 | 1:1.4 | NDe | |||
| 14 | 58 | 2.3:1 | NDd | |||
| 15 | 80 | 2.3:1 | NDd | |||
| 16 | 88 | 1.4:1 | 8 syn- | 99% | ||
aIsolated yields; bdr determined by 1H NMR; cpurity established by LCMS/ELS; dcompound 6 detected; ecompound 6 not detected.
Library of tetrahydro-β-carbolinecyclobutenes 2{1,3}–2{1,8}.
| entry | R2 | yield of | methodb | yield of | purityc | |
| 1 | 0 | — | — | — | ||
| 2 | 64 | A | NDd | — | ||
| 3 | 75e
| A | 73 | 99% | ||
| 4 | 71 | A | 57 | 99% | ||
| 5 | A | 57f
| 99% | |||
| 6 | B | 41 | 99% | |||
| 7 | B | 30 | 99% | |||
| 8 | B | 33 | 99% | |||
aIsolated yield; bmethod A: μW, 160 °C, DMF, 10 min; method B: Placed in front of two 6 W UV lamps (245 nm), CH2Cl2, rt, 16 h, no stirring; cpurity established by LCMS/ELS; dND = not detected; eμW, 225 °C, DMF, 7 min, (39%); fseparated 9{1,5} (57% yield) from 2{1,5} (18% yield) after the coupling reaction then submitted 9{1,5} to method A to give 2{1,5} in 68% yield. This compound was recombined with the previously isolated 2{1,5} to afford a combined 57% yield.
Synthesis of α-methylenecyclopentenone library 3{1,3}–3{1,4}.
| entry | R2 | yield of | purityb | |
| 1 | 48 | 99% | ||
| 2 | 46 | 99% | ||
aIsolated yields; bpurity determined by LCMS/ELS.
Figure 2Library of tetrahydro-β-carboline containing compounds 1–7 and calculated properties (amolecular weight; bhydrogen-bond donor/acceptors; ccLogP; dpolar surface area (PSA)).
Figure 3Results of high-throughput docking analysis. Top: A docking-score matrix arranged by compound IDs and PDB IDs; bottom: Structures of known ligands HR2 and TGF and the newly synthesized compounds 2{1,5} and 2{1,7}. Docking scores larger than 7.0 are red colored and can be mapped to Kd values less than 100 nM. The corresponding protein names of PDB IDs and the full docking-score matrix are listed in Supporting Information File 1.
Potential targets of β-carbolines based upon bioactivity data in ChEMBL.
| target | CHEMBL compound | bioactivity | our compound | similarity score |
| C–C chemokine receptor type 3 | IC50 = 325 nM [ | 0.79 | ||
| Leishmania donovani | IC50 = 1.42 µM [ | 0.80 | ||
| Acanthocheilonema viteae | Activity = 94% [ | 0.86 | ||
| Gamma-aminobutyric acid receptor subunit gamma-2 | IC50 = 250 nM [ | 0.84 | ||
| 5-Hydroxytryptamine receptor 6 | 0.69 | |||
| 3-Hydroxyacyl-CoA dehydrogenase type-2 | Potency = 31.6 µM PubChem AID:893 | 0.64 | ||
| Benzodiazepine receptors | 0.72 | |||
| Angiotensin-converting enzyme | IC50 = 500 nM [ | 0.71 | ||
| Antithrombotic potency | IC50 = 8.56 nM [ | 0.69 | ||
| Mitogen-activated protein kinase 1 | Potency = 0.794 µM PubChem AID:995 | 0.82 | ||
| Breast adenocarcinoma cells | Inhibition = 78% [ | 0.79 | ||
| DNA polymerase iota | Potency = 1.78 µM PubChem AID:588590 | 0.85 | ||